Clinical Trials for KeChow Pharma

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: KeChow Pharma

Clinical Trials (4)

NCT06867393
Safety, Tolerability, and Pharmacokinetics of HL-003 in Healthy Subjects
PHASE1Recruiting
52 participants
Started: Feb 28, 2025 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT06008106
Comparing Tunlametinib Capsules and Combination Chemotherapy in Advanced NRAS-mutant Melanoma
PHASE3Recruiting
165 participants
Started: Nov 2, 2023 · Completed: Sep 22, 2027
1 condition1 sponsor1 location
NCT06008119
Efficacy and Safety of Tunlametinib Plus Vemurafenib in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer
PHASE3Recruiting
165 participants
Started: Oct 25, 2023 · Completed: Dec 24, 2026
1 condition1 sponsor1 location
NCT05331105
HL-085 in Adults With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas
PHASE2Recruiting
70 participants
Started: Oct 18, 2021 · Completed: Oct 31, 2028
2 conditions1 sponsor1 location